Carbon Monoxide Rescues Mice from Lethal Sepsis by Supporting Mitochondrial Energetic Metabolism and Activating Mitochondrial Biogenesis

Use of metal carbonyl-based compounds capable of releasing carbon monoxide (CO) in biological systems have emerged as a potential adjunctive therapy for sepsis via their antioxidant, anti-inflammatory, and antiapoptotic effects. The role of CO in regulation of mitochondrial dysfunction and biogenesis associated with sepsis has not been investigated. In the present study, we employed a ruthenium-based water-soluble CO carrier, tricarbonylchoro(glycinato)ruthenium (II) (CORM-3), one of the novel CO-releasing molecules (CO-RMs), to test whether CO can improve cardiac mitochondrial dysfunction and survival in peritonitis-induced sepsis. Peritonitis was performed in mice by cecal ligation and perforation. Tumor necrosis factor-α, interleukin-10, and nitrite/nitrate plasma levels were tested to evaluate the systemic inflammatory response. Functional mitochondrial studies included determination of membrane potential, respiration, and redox status. Oxidative stress was evaluated by measurements of mitochondrial hydrogen peroxide, carbonyl protein and GSH levels. Mitochondrial biogenesis was assessed by peroxisome proliferator-activated receptor γ coactivator (PGC)-1α protein expression and mitochondrial DNA (mtDNA) copy number. The systemic inflammatory response elicited by peritonitis was accompanied by mitochondrial energetic metabolism deterioration and reduced PGC-1α protein expression. CORM-3 treatment in septic mice restored the deleterious effects of sepsis on mitochondrial membrane potential, respiratory control ratio, and energetics. It is interesting that administration of CORM-3 during sepsis elicited a mild oxidative stress response that stimulated mitochondrial biogenesis with PGC-1α protein expression and mtDNA copy number increases. Our results reveal that delivery of controlled amounts of CO dramatically reduced mortality in septic mice, indicating that CO-RMs could be used therapeutically to prevent organ dysfunction and death in sepsis.

[1]  Ping Zhang,et al.  Preconditioning of Carbon Monoxide Releasing Molecule-derived CO Attenuates LPS-induced Activation of HUVEC , 2008, International journal of biological sciences.

[2]  Mervyn Singer,et al.  Cellular energetic metabolism in sepsis: the need for a systems approach. , 2008, Biochimica et biophysica acta.

[3]  E. Murphy,et al.  Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. , 2008, Physiological reviews.

[4]  R. Scarpulla Transcriptional paradigms in mammalian mitochondrial biogenesis and function. , 2008, Physiological reviews.

[5]  S. Chung,et al.  Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice. , 2008, The Journal of clinical investigation.

[6]  R. Potter,et al.  Carbon monoxide liberated from carbon monoxide-releasing molecule CORM-2 attenuates inflammation in the liver of septic mice. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[7]  X. Chen,et al.  Carbon liberated from CO-releasing molecules attenuates leukocyte infiltration in the small intestine of thermally injured mice. , 2007, World journal of gastroenterology.

[8]  M. Carraway,et al.  The CO/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy. , 2007, The Journal of clinical investigation.

[9]  J. Poderoso,et al.  Mitochondrial and cellular heme-dependent proteins as targets for the bioactive function of the heme oxygenase/carbon monoxide system. , 2007, Antioxidants & redox signaling.

[10]  R. Motterlini Carbon monoxide-releasing molecules (CO-RMs): vasodilatory, anti-ischaemic and anti-inflammatory activities. , 2007, Biochemical Society transactions.

[11]  S. Ryter,et al.  Carbon monoxide in sepsis. , 2007, Antioxidants & redox signaling.

[12]  M. Singer,et al.  Mechanisms of sepsis-induced organ dysfunction , 2007, Critical care medicine.

[13]  C. Deutschman,et al.  Myocardial cytochrome oxidase activity is decreased following carbon monoxide exposure. , 2007, Biochimica et biophysica acta.

[14]  T. Billiar,et al.  Carbon monoxide signals via inhibition of cytochrome c oxidase and generation of mitochondrial reactive oxygen species , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  M. Carraway,et al.  A new activating role for CO in cardiac mitochondrial biogenesis , 2007, Journal of Cell Science.

[16]  S. Ryter,et al.  Cytoprotective and anti-inflammatory actions of carbon monoxide in organ injury and sepsis models. , 2007, Novartis Foundation symposium.

[17]  S. Ryter,et al.  Mechanisms of cell death in oxidative stress. , 2007, Antioxidants & redox signaling.

[18]  J. Poderoso,et al.  CO-metal interaction: Vital signaling from a lethal gas. , 2006, Trends in biochemical sciences.

[19]  S. Ryter,et al.  CO as a cellular signaling molecule. , 2006, Annual review of pharmacology and toxicology.

[20]  R. Foresti,et al.  Treatment with CO-RMs during cold storage improves renal function at reperfusion. , 2006, Kidney international.

[21]  F. Bach,et al.  Carbon monoxide pretreatment prevents respiratory derangement and ameliorates hyperacute endotoxic shock in pigs , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[22]  R. Foresti,et al.  Therapeutic applications of carbon monoxide-releasing molecules , 2005, Expert opinion on investigational drugs.

[23]  R. Foresti,et al.  Carbon monoxide‐releasing molecules (CO‐RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages , 2005, British journal of pharmacology.

[24]  O. Wagner,et al.  Effects of carbon monoxide inhalation during experimental endotoxemia in humans. , 2005, American journal of respiratory and critical care medicine.

[25]  Djillali Annane,et al.  Septic shock , 2005, The Lancet.

[26]  G. Stassi,et al.  Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[27]  O. Wagner,et al.  Carbon monoxide protection against endotoxic shock involves reciprocal effects on iNOS in the lung and liver , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[28]  P. Naughton,et al.  Cardioprotective Actions by a Water‐Soluble Carbon nMonoxide‐Releasing Molecule , 2003, Circulation research.

[29]  D. Mannino,et al.  The epidemiology of sepsis in the United States from 1979 through 2000. , 2003, The New England journal of medicine.

[30]  Jorge D. Erusalimsky,et al.  Does nitric oxide modulate mitochondrial energy generation and apoptosis? , 2002, Nature Reviews Molecular Cell Biology.

[31]  A. Choi,et al.  Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway , 2000, Nature Medicine.

[32]  Potier Jc,et al.  Carbon monoxide poisoning , 1973 .

[33]  G. Richards,et al.  The epidemiology of sepsis. , 1973, Clinical orthopaedics and related research.